In the first of a two-part series with TB and HIV experts at the Bill & Melinda Gates Foundation, Dr. Stefano Bertozzi, director of HIV and tuberculosis programs at the Foundation, gives his thoughts on what lies ahead this year in HIV and TB building on key developments from the past year and a half. In his role, Dr. Bertozzi oversees grants in HIV vaccine development, biomedical prevention research, diagnostics development and resistance monitoring, and strategies for introduction and scaling-up of interventions. He has held past leadership roles at UNAIDS, the World Health Organization, the World Bank, and the National Institute of Public Health (INSP) in Mexico.
With promise to “eliminate the HIV epidemic,” and “defeat AIDS in America and beyond,” administration raises questions about policies
While plan will target 48 “hot spots” with services, and people at high risks with PrEP, will it change policies that fuel HIV? More details are […]
WHO releases updated drug-resistant TB guidelines, removing toxic injectables from recommended treatments
With the release of a “pre-final text” of updated guidelines for treatment of multidrug- and rifampicin-resistant tuberculosis, the World Health Organization made official substantial changes to […]
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Planned Parenthood “Global Gag Rule” report is latest to diverge sharply from State Department assessment that policy does no harm
Drawing on previously published findings and on-the-ground interviews, a report from Planned Parenthood details damage to global health gains, including in closed programs, weakened civil society, […]